Statistics for Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Total visits
| views | |
|---|---|
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial | 10 |
Total visits per month
| views | |
|---|---|
| March 2025 | 0 |
| April 2025 | 4 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 1 |
| August 2025 | 4 |
| September 2025 | 0 |